| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.095 | 0.04 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.094 | 0.04 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.068 | 0.04 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.04 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.15 | 0.05 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.05 |